Innate Pharma SA logo

Innate Pharma SA - Class A

NEW
XPAR:IPH (France)   Class A
€ 1.528 -0.0020 (-0.13%) Aug 3
At Loss
Market Cap:
€ 143.48M ($ 165.45M)
Enterprise V:
€ 131.75M ($ 151.92M)
Volume:
84.76K
Avg Vol (2M):
131.47K
Trade In:
Volume:
84.76K
At Loss

Innate Pharma SA (XPAR:IPH) Dividend

Innate Pharma SA (XPAR:IPH) does not currently pay a regular dividend. Over the past 3 years it has returned capital to shareholders via buybacks at a rate of -5.6%. View its historical dividend record below and compare with dividend-paying peers.

Frequently Asked Questions: XPAR:IPH Dividend

Does Innate Pharma SA (XPAR:IPH) pay a dividend?

Innate Pharma SA (XPAR:IPH) does not currently pay a regular dividend. Review the historical record above for any past dividend payments or capital return policies.

Why doesn't Innate Pharma SA pay a dividend?

Companies typically forgo dividends to reinvest earnings into growth, R&D, acquisitions, or share buybacks. Innate Pharma SA has returned capital to shareholders via buybacks at a rate of -5.6% over the past 3 years.

What are dividend-paying alternatives to Innate Pharma SA?

For dividend-paying alternatives in Innate Pharma SA's sector, view dividend stocks by industry on GuruFocus's dividend stock screener.